Bactiguard Holding AB's Interim Report Q2 2023

Strategy of bolstering Licensing and US go-to-market stays firm

Second Quarter 2023


Total revenues amounted to SEK 51.2 million, a decrease of 15 %. Net sales amounted to SEK 44.2 million....

Related Keywords

Sweden ,Milan ,Lombardia ,Italy ,Japan ,Malaysia ,Stockholm ,Richard Kuntz ,Zimmer Biomet ,Dentsply Sirona ,Mikael Sander ,Nina Nornholm ,Bactiguard Holding ,Wounds International ,Council Of The European Union ,Global Head ,Scientific Officer ,Executive Committee ,Wound Care ,Bactiguard Wound Care ,European Union ,Abuse Regulation ,Securities Markets ,Bactiguard Product Portfolio ,Nasdaq Stockholm ,Markets ,